Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03579433 · ClinicalTrials.gov registry record · NA
Postmarket Study of an Intraocular Lens Power Selection System
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT03579433 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 124 participants.
The verdict
NCT03579433, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
The purpose of the study was to evaluate the visual acuity outcomes when using the Optiwave Refractive Analysis (ORA) with VerifEye+ and Barrett Toric Calculator for calculating intraocular lens (IOL) power and axis in subjects requiring cataract surgery and implanted with a toric IOL in both eyes.
Interventions
- DEVICE ORA with VerifEye+
- OTHER Alcon Barrett Toric Calculator
- DEVICE Acrysof® IQ Toric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2018-08-16 |
| Est. Completion | 2019-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03579433
The ClinicalTrials.gov registry entry for NCT03579433 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ORA with VerifEye+ is the first listed.
NCT03579433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03579433 about?
NCT03579433 is a clinical study titled "Postmarket Study of an Intraocular Lens Power Selection System". The purpose of the study was to evaluate the visual acuity outcomes when using the Optiwave Refractive Analysis (ORA) with VerifEye+ and Barrett Toric Calculator for calculating intraocular lens (IOL) power and axis in subjects requiring cataract surgery and implanted with a toric IOL in both eyes.
What is the current status of trial NCT03579433?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2018-08-16. Estimated completion is 2019-04-16.
What interventions are being tested in trial NCT03579433?
The interventions under investigation include: ORA with VerifEye+ (DEVICE), Alcon Barrett Toric Calculator (OTHER), Acrysof® IQ Toric IOL (DEVICE).
Who is sponsoring clinical trial NCT03579433?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.